cbdMD’s CBD PM and CBD Freeze Awarded 2020 Product of the Year
February 07 2020 - 6:00AM
Business Wire
Summary: Both products, CBD PM and CBD Freeze,
have been voted the 2020 Product of the Year winner in the CBD
Sleep Aid and CBD Topical categories.
cbdMD, Inc. a nationally recognized consumer cannabidiol (CBD)
brand (NYSE American: YCBD), is pleased to announce that their
CBD PM and CBD Freeze products have been voted the
winner of the prestigious 2020 Product of the Year award in
the CBD Sleep Aid and CBD Topical categories, respectively.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20200207005067/en/
This is America’s largest consumer-voted award for product
innovation, as 40,000 voters participated in an online study
organized by independent research firm Kantar Media Group. cbdMD
Chief Marketing Officer, Ken Cohn, accepted the award on behalf of
the company during a special ceremony in New York City last
night.
CBD PM is a premium sleep aid containing superior broad spectrum
CBD, melatonin, and a unique blend of soothing herbs. The CBD
Freeze combines the pain-relieving properties of menthol with the
natural power of domestically sourced CBD. This was the first year
that Product of the Year USA provided a category for CBD
companies. cbdMD is the first and only CBD company to win a Product
of the Year award.
“These awards are the culmination of everyone’s effort, and I
couldn’t be more proud,” said Martin Sumichrast, Chairman and
co-CEO of cbdMD. “As a company, we’ve worked tirelessly to set the
standard for quality in this industry, and the Product of the Year
distinction provides real validity to all our efforts.”
“We are so honored to be the first CBD company to receive a
Product of the Year award for our CBD PM and CBD Freeze products,”
said Ken Cohn, Chief Marketing Officer at cbdMD. “We’re excited to
be recognized amongst the elite companies and brands that Product
of the Year highlights every year.”
The Product of the Year award operates in 38 countries around
the world. The distinctive red “Voted Product of the Year” seal
will be leveraged across all marketing channels, including product
packaging, advertising, promotions, social media accounts, and
brand website.
For more information on cbdMD, please visit www.cbdmd.com
About cbdMD
cbdMD, Inc. is a nationally recognized consumer cannabidiol
(CBD) brand whose current products include CBD tinctures, CBD
gummies, CBD topicals, CBD bath bombs, and CBD pet products. cbdMD
is also a proud partner of Bellator MMA, Life Time, Inc., and
Supercross, and has one of the largest rosters of professional
sports athletes who are part of “Team cbdMD.” To learn more about
cbdMD and our comprehensive line of over 100 SKUs of U.S. produced,
THC-free* CBD products, please visit www.cbdmd.com, follow cbdMD on
Instagram and Facebook, or visit one of the 4,000 retail outlets
that carry cbdMD products.
About Product of the Year
Product of the Year is the world's largest consumer-voted award
for product innovation. Established 30 years ago, POY currently
operates in 38 countries with the same purpose: Guide consumers to
the best products in their market and reward manufacturers for
quality and innovation. Product of the Year winners are backed by
the votes of over 40,000 consumers in a nationally representative
survey conducted by research partner Kantar TNS, a global leader in
consumer research. The award is a powerful merchandising program
for marketers proven to increase product sales, distribution, and
awareness. Winning products are announced in February each year and
receive the right to use the Product of the Year seal in marketing
communications for two years. For more information, visit
productoftheyearusa.com.
Forward-Looking Statements
This press release contains certain forward-looking statements
that are based upon current expectations and involve certain risks
and uncertainties within the meaning of the U.S. Private Securities
Litigation Reform Act of 1995. Such forward-looking statements can
be identified by the use of words such as ″should,″ ″may,″
″intends,″ ″anticipates,″ ″believes,″ ″estimates,″ ″projects,″
″forecasts,″ ″expects,″ ″plans,″ and ″proposes.″ These
forward-looking statements are not guarantees of future performance
and are subject to risks, uncertainties, and other factors, some of
which are beyond our control and difficult to predict and could
cause actual results to differ materially from those expressed or
forecasted in the forward-looking statements. You are urged to
carefully review and consider any cautionary statements and other
disclosures, including the statements made under the heading “Risk
Factors” in cbdMD, Inc.’s Annual Report on Form 10-K for the fiscal
year ended September 30, 2019, as filed with the Securities and
Exchange Commission (the “SEC”), and our other filings with the
SEC. All forward-looking statements involve significant risks and
uncertainties that could cause actual results to differ materially
from those in the forward-looking statements, many of which are
generally outside the control of cbdMD, Inc. and are difficult to
predict. cbdMD, Inc. does not undertake any duty to update any
forward-looking statements except as may be required by law. The
information which appears on our websites and our social media
platforms, including, but not limited to, Instagram and Facebook,
is not part of this press release.
*THC-free is defined as below the level of detection using valid
scientific analytical tools.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200207005067/en/
cbdMD PR PR@cbdMD.com 1 (800) 973-3984
Investors: John Weston john.weston@cbdMD.com 704-249-9515
cbdMD (AMEX:YCBD)
Historical Stock Chart
From Mar 2024 to Apr 2024
cbdMD (AMEX:YCBD)
Historical Stock Chart
From Apr 2023 to Apr 2024